Skip to main content

Table 1 Baseline characteristics of study participants according to treatment arm (artemether–lumefantrine vs. artesunate–amodiaquine) at four sites in Mozambique, 2018

From: In vivo efficacy and safety of artemether–lumefantrine and amodiaquine–artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018

Artemether–lumefantrine

Study site

Massinga (N = 95)

Moatize (N = 92)

Montepuez (N = 90)

Mopeia (N = 91)

Female gender n (%)

42 (44.2)

45 (48.9)

46 (51.1)

38 (41.8)

Age in months (mean ± SD)

27.8 ± 14.8

34.5 ± 15.5

24 ± 15.3

30.1 ± 12.7

Weight in kg (mean ± SD)

10.7 ± 3.9

12.7 ± 3.1

9.4 ± 3.7

11.1 ± 1.9

Fever n (%)

95 (100)

92 (100)

89 (98.9)

90 (98.9)

Temperature in °C (mean ± SD)

38.4 ± 0.9

38.8 ± 1

38.3 ± 0.8

38 ± 0.6

Parasite density geometric mean (range)

24,414.2 (779–184,355)

43,265.3 (646–192,875)

46,603.7 (3060–183,724)

44,131.7 (2201–184,955)

Hb in g/dl (mean ± SD)

8.7 ± 1.8

10.2 ± 1.5

9.1 ± 1.7

9.4 ± 1.6

Artesunate–amodiaquine

Massinga (N = 92)

Moatize (N = 0)

Montepuez (N = 90)

Mopeia (N = 91)

Female gender n (%)

42 (45.7)

NA

34 (37.8)

45 (49.5)

Age in months (mean ± SD)

30.8 ± 14.4

NA

24.8 ± 14.8

30.1 ± 13.8

Weight in kg (mean ± SD)

10 ± 5.1

NA

10.5 ± 2.5

11.8 ± 2.3

Fever n (%)

92 (100)

NA

89 (98.9)

91 (100)

Temperature in °C (mean ± SD)

38.4 ± 0.9

NA

38.4 ± 0.9

37.8 ± 0.4

Parasite density geometric mean (range)

32,081.4 (1845–204,526)

NA

34,703.6 (2757–140,929)

34,293.9 (2154–173,070)

Hb in g/dl (mean ± SD)

8.9 ± 2

NA

9.5 ± 1.7

9.1 ± 1.4

  1. AL: artemether–lumefantrine; AS–AQ: artesunate–amodiaquine; Fever: axillary temperature ≥ 37.5 °C or history of fever during the 24 h before recruitment; Hb: haemoglobin; SD: standard deviation; NA: not applicable